カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の基底細胞癌治療薬市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Basal Cell Carcinoma Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7787）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7787
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の基底細胞癌治療薬市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の基底細胞癌治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の基底細胞癌治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 基底細胞癌治療薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

基底細胞癌治療薬市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・局所治療、ハリネズミ経路阻害剤療法

用途別セグメント
・病院、専門クリニック、その他

主要な市場プレーヤー
・Roche、Sun Pharmaceuticals、Bausch Health Companies、Taro Pharmaceuticals、Viatris

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、基底細胞癌治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な基底細胞癌治療薬メーカーの企業概要、2019年～2022年までの基底細胞癌治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な基底細胞癌治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別基底細胞癌治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの基底細胞癌治療薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での基底細胞癌治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および基底細胞癌治療薬の産業チェーンを掲載しています。
・第14、15章では、基底細胞癌治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 基底細胞癌治療薬の概要
– タイプ別分析（2018年vs2022年vs2029年）：局所治療、ハリネズミ経路阻害剤療法
– 用途別分析（2018年vs2022年vs2029年）：病院、専門クリニック、その他
– 世界の基底細胞癌治療薬市場規模・予測
– 世界の基底細胞癌治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Roche、Sun Pharmaceuticals、Bausch Health Companies、Taro Pharmaceuticals、Viatris
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：局所治療、ハリネズミ経路阻害剤療法
・用途別分析2018年-2029年：病院、専門クリニック、その他
・基底細胞癌治療薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・基底細胞癌治療薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・基底細胞癌治療薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・基底細胞癌治療薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・基底細胞癌治療薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Basal Cell Carcinoma Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Basal Cell Carcinoma Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Topical Treatment
1.3.3 Hedgehog Pathway Inhibitor Therapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Basal Cell Carcinoma Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Others
1.5 Global Basal Cell Carcinoma Drug Market Size & Forecast
1.5.1 Global Basal Cell Carcinoma Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Basal Cell Carcinoma Drug Sales Quantity (2018-2029)
1.5.3 Global Basal Cell Carcinoma Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Basal Cell Carcinoma Drug Product and Services
2.1.4 Roche Basal Cell Carcinoma Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Sun Pharmaceuticals
2.2.1 Sun Pharmaceuticals Details
2.2.2 Sun Pharmaceuticals Major Business
2.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Drug Product and Services
2.2.4 Sun Pharmaceuticals Basal Cell Carcinoma Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sun Pharmaceuticals Recent Developments/Updates
2.3 Bausch Health Companies
2.3.1 Bausch Health Companies Details
2.3.2 Bausch Health Companies Major Business
2.3.3 Bausch Health Companies Basal Cell Carcinoma Drug Product and Services
2.3.4 Bausch Health Companies Basal Cell Carcinoma Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bausch Health Companies Recent Developments/Updates
2.4 Taro Pharmaceuticals
2.4.1 Taro Pharmaceuticals Details
2.4.2 Taro Pharmaceuticals Major Business
2.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Drug Product and Services
2.4.4 Taro Pharmaceuticals Basal Cell Carcinoma Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Taro Pharmaceuticals Recent Developments/Updates
2.5 Viatris
2.5.1 Viatris Details
2.5.2 Viatris Major Business
2.5.3 Viatris Basal Cell Carcinoma Drug Product and Services
2.5.4 Viatris Basal Cell Carcinoma Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Viatris Recent Developments/Updates
3 Competitive Environment: Basal Cell Carcinoma Drug by Manufacturer
3.1 Global Basal Cell Carcinoma Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Basal Cell Carcinoma Drug Revenue by Manufacturer (2018-2023)
3.3 Global Basal Cell Carcinoma Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Basal Cell Carcinoma Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Basal Cell Carcinoma Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Basal Cell Carcinoma Drug Manufacturer Market Share in 2022
3.5 Basal Cell Carcinoma Drug Market: Overall Company Footprint Analysis
3.5.1 Basal Cell Carcinoma Drug Market: Region Footprint
3.5.2 Basal Cell Carcinoma Drug Market: Company Product Type Footprint
3.5.3 Basal Cell Carcinoma Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Basal Cell Carcinoma Drug Market Size by Region
4.1.1 Global Basal Cell Carcinoma Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Basal Cell Carcinoma Drug Consumption Value by Region (2018-2029)
4.1.3 Global Basal Cell Carcinoma Drug Average Price by Region (2018-2029)
4.2 North America Basal Cell Carcinoma Drug Consumption Value (2018-2029)
4.3 Europe Basal Cell Carcinoma Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Basal Cell Carcinoma Drug Consumption Value (2018-2029)
4.5 South America Basal Cell Carcinoma Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Basal Cell Carcinoma Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
5.2 Global Basal Cell Carcinoma Drug Consumption Value by Type (2018-2029)
5.3 Global Basal Cell Carcinoma Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
6.2 Global Basal Cell Carcinoma Drug Consumption Value by Application (2018-2029)
6.3 Global Basal Cell Carcinoma Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
7.2 North America Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
7.3 North America Basal Cell Carcinoma Drug Market Size by Country
7.3.1 North America Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Basal Cell Carcinoma Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
8.2 Europe Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
8.3 Europe Basal Cell Carcinoma Drug Market Size by Country
8.3.1 Europe Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Basal Cell Carcinoma Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Basal Cell Carcinoma Drug Market Size by Region
9.3.1 Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Basal Cell Carcinoma Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
10.2 South America Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
10.3 South America Basal Cell Carcinoma Drug Market Size by Country
10.3.1 South America Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Basal Cell Carcinoma Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Basal Cell Carcinoma Drug Market Size by Country
11.3.1 Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Basal Cell Carcinoma Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Basal Cell Carcinoma Drug Market Drivers
12.2 Basal Cell Carcinoma Drug Market Restraints
12.3 Basal Cell Carcinoma Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Basal Cell Carcinoma Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Basal Cell Carcinoma Drug
13.3 Basal Cell Carcinoma Drug Production Process
13.4 Basal Cell Carcinoma Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Basal Cell Carcinoma Drug Typical Distributors
14.3 Basal Cell Carcinoma Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Basal Cell Carcinoma Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Basal Cell Carcinoma Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Basal Cell Carcinoma Drug Product and Services
Table 6. Roche Basal Cell Carcinoma Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharmaceuticals Major Business
Table 10. Sun Pharmaceuticals Basal Cell Carcinoma Drug Product and Services
Table 11. Sun Pharmaceuticals Basal Cell Carcinoma Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sun Pharmaceuticals Recent Developments/Updates
Table 13. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 14. Bausch Health Companies Major Business
Table 15. Bausch Health Companies Basal Cell Carcinoma Drug Product and Services
Table 16. Bausch Health Companies Basal Cell Carcinoma Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bausch Health Companies Recent Developments/Updates
Table 18. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Taro Pharmaceuticals Major Business
Table 20. Taro Pharmaceuticals Basal Cell Carcinoma Drug Product and Services
Table 21. Taro Pharmaceuticals Basal Cell Carcinoma Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Taro Pharmaceuticals Recent Developments/Updates
Table 23. Viatris Basic Information, Manufacturing Base and Competitors
Table 24. Viatris Major Business
Table 25. Viatris Basal Cell Carcinoma Drug Product and Services
Table 26. Viatris Basal Cell Carcinoma Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Viatris Recent Developments/Updates
Table 28. Global Basal Cell Carcinoma Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Basal Cell Carcinoma Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Basal Cell Carcinoma Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in Basal Cell Carcinoma Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Basal Cell Carcinoma Drug Production Site of Key Manufacturer
Table 33. Basal Cell Carcinoma Drug Market: Company Product Type Footprint
Table 34. Basal Cell Carcinoma Drug Market: Company Product Application Footprint
Table 35. Basal Cell Carcinoma Drug New Market Entrants and Barriers to Market Entry
Table 36. Basal Cell Carcinoma Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Basal Cell Carcinoma Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Basal Cell Carcinoma Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Basal Cell Carcinoma Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Basal Cell Carcinoma Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Basal Cell Carcinoma Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global Basal Cell Carcinoma Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global Basal Cell Carcinoma Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Basal Cell Carcinoma Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Basal Cell Carcinoma Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global Basal Cell Carcinoma Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global Basal Cell Carcinoma Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Basal Cell Carcinoma Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Basal Cell Carcinoma Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Basal Cell Carcinoma Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Basal Cell Carcinoma Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Basal Cell Carcinoma Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Basal Cell Carcinoma Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Basal Cell Carcinoma Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Basal Cell Carcinoma Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Basal Cell Carcinoma Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Basal Cell Carcinoma Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Basal Cell Carcinoma Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America Basal Cell Carcinoma Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Basal Cell Carcinoma Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Basal Cell Carcinoma Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Basal Cell Carcinoma Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Basal Cell Carcinoma Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Basal Cell Carcinoma Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Basal Cell Carcinoma Drug Raw Material
Table 96. Key Manufacturers of Basal Cell Carcinoma Drug Raw Materials
Table 97. Basal Cell Carcinoma Drug Typical Distributors
Table 98. Basal Cell Carcinoma Drug Typical Customers
List of Figures
Figure 1. Basal Cell Carcinoma Drug Picture
Figure 2. Global Basal Cell Carcinoma Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Type in 2022
Figure 4. Topical Treatment Examples
Figure 5. Hedgehog Pathway Inhibitor Therapy Examples
Figure 6. Global Basal Cell Carcinoma Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Specialty Clinics Examples
Figure 10. Others Examples
Figure 11. Global Basal Cell Carcinoma Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Basal Cell Carcinoma Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Basal Cell Carcinoma Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Basal Cell Carcinoma Drug Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Basal Cell Carcinoma Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Basal Cell Carcinoma Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Basal Cell Carcinoma Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Basal Cell Carcinoma Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Basal Cell Carcinoma Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Basal Cell Carcinoma Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Basal Cell Carcinoma Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Basal Cell Carcinoma Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Basal Cell Carcinoma Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Basal Cell Carcinoma Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Basal Cell Carcinoma Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Basal Cell Carcinoma Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Basal Cell Carcinoma Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Basal Cell Carcinoma Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Basal Cell Carcinoma Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Basal Cell Carcinoma Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Basal Cell Carcinoma Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Basal Cell Carcinoma Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Basal Cell Carcinoma Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Basal Cell Carcinoma Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Basal Cell Carcinoma Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Basal Cell Carcinoma Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Basal Cell Carcinoma Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Basal Cell Carcinoma Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Basal Cell Carcinoma Drug Market Drivers
Figure 74. Basal Cell Carcinoma Drug Market Restraints
Figure 75. Basal Cell Carcinoma Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Basal Cell Carcinoma Drug in 2022
Figure 78. Manufacturing Process Analysis of Basal Cell Carcinoma Drug
Figure 79. Basal Cell Carcinoma Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のカルシニューリン阻害薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の更年期ホルモン剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のCHO細胞培養培地市場2023年：企業・地域・タイプ・用途別分析
  • 世界の動物精子細胞凍結保存培地市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7787 )"世界の基底細胞癌治療薬市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Basal Cell Carcinoma Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。